bioRxivCell Biology
Hypoxic Preconditioning Promotes Survivals of Human Adipocyte Mesenchymal Stem Cell via Expression of Prosurvival and Proangiogenic Biomarkers
I. G. R. Suryawan, B. S. Pikir, F. A. Rantam, A. K. Ratri, R. A. Nugraha
Abstract
BackgroundContributing factors for improved survival of human adipocytes mesenchymal stem cells (h-AMSCs) cultured through hypoxia preconditioning, in example apoptosis inhibition involving BCL2 and HSP27 expression, trigger signal expression (VEGF), SCF expression, OCT-4 expression, and CD44+ expression. ObjectiveTo explain the mechanism and role of hypoxic preconditioning and the optimal duration of hypoxic preconditioning exposure to improve survival of h-AMSCs so that could it could be used as a benchmark for h-AMSCs culture strategy before transplantation. MethodsThis study was an experimental laboratory explorative study (in vitro study) with hypoxic preconditioning in human-adipose mesenchymal stem cells (h-AMSCs) cultures. This research was conducted through 4 stages ;First, Isolation and h-AMSCs culture from adipose tissue of patient (human). Second is the characterization of h-AMSCs from adipose tissue by phenotype (Flowcytometry) through CD44+, CD90+ and CD45-expression before being pre-conditioned for hypoxic treatment. Third, the hypoxic preconditioning in h-AMSCs culture (in vitro) was performed with an oxygen concentration of 1% for 24, 48 and 72 hours. Fourth, observation of survival from h-AMSCs culture was tested on the role of CD44 +, VEGF, SCF, OCT-4, BCL2, HSP27 with Flowcytometry method and apoptotic inhibition by Tunnel Assay method. ResultsThe result of regression test showed that time difference had an effect on VEGF expression (p=0,000; {beta}=-0,482) and hypoxia condition also influenced VEGF expression (p= 0,000; {beta}=0,774). The result of path analysis showed that SCF had an effect on OCT-4 expression (p=0,000; {beta}=0,985). The regression test results showed that time effects on HSP27 expression (p=0.000; {beta}=0.398) and hypoxia precondition also affects HSP27 expression (p=0.000; {beta}=0.847). Pathway analysis showed that BCL2 expression inhibited apoptosis (p=0.030; {beta}=-0.442) and HSP27 expression also inhibited apoptosis (p=0,000; {beta}=-0.487). ConclusionIn conclusion, hypoxic preconditioning of h-AMSC culture has proven to increase the expression of VEGF, SCF, OCT-4, and BCL2 and HSP27. This study demonstrated and explained the existence of a new mechanism of increased h-AMSC survival in cultures with hypoxic preconditioning (O2 1%) via VEGF, SCF, OCT-4, BCL2, and HSP 27. But CD 44+ did not play a role in the mechanism of survival improvement of human AMSC survival.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Metabolic reprogramming and partial acquisition of cancer stem cell-like phenotype in human umbilical cord-mesenchymal stem cells under hypoxia
Yoshihiro Kushida, Kana Abe, Yo Oguma·bioRxiv·Mar 13, 2026
- Development of a rocking bioreactor strategy to augment pro-angiogenic factor secretion by human adipose-derived stromal cells
Zhiyu Liang, Connor J. Gillis, … Lauren E. Flynn·bioRxiv·Aug 19, 2026
- Synergistic Hypoxia and Apoptosis Conditioning Unleashes Superior Mesenchymal Stem Cells Efficacy in Acute Graft-versus-Host-Disease
M. Mendiratta, M. Mendiratta, … R. K. Sahoo·bioRxiv·Apr 11, 2024
- Influence of Hypoxia on a Biomaterial Model of the Bone Marrow Perivascular Niche
Gunnar B. Thompson, Victoria R. Barnhouse, … Brendan A.C. Harley·Advanced Healthcare MaterialsPeer-reviewed·Apr 26, 2025
- Hypoxia-Mediated Molecular Interactions of Tissue-Specific Mesenchymal Stem Cells Drive Metabolic Reprogramming and Immunomodulation in Acute Graft-versus-Host Disease
Mohini Mendiratta, Meenakshi Mendiratta, … Ranjit Kumar Sahoo·bioRxiv·Jan 6, 2025
- Dual Preconditioned Mesenchymal Stem Cells-Derived Culture Conditioned Media Augment Immunomodulation and Drive Metabolic Reprogramming in Acute Graft-versus-Host Disease
Mohini Mendiratta, Meenakshi Mendiratta, … Ranjit Kumar Sahoo·bioRxiv·Nov 2, 2025